N. V. Rao

1.2k total citations
25 papers, 1.0k citations indexed

About

N. V. Rao is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, N. V. Rao has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in N. V. Rao's work include Protease and Inhibitor Mechanisms (6 papers), Neonatal Respiratory Health Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). N. V. Rao is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Neonatal Respiratory Health Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). N. V. Rao collaborates with scholars based in United States, India and Vietnam. N. V. Rao's co-authors include John R. Hoidal, Bruce C. Marshall, Thomas P. Kennedy, Nancy Wehner, William R. Gray, Chris Hopkins, Elizabeth A. Tolley, Larry R. Pennington, S. A. Haider and Brent R. Brown and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Biochemical and Biophysical Research Communications.

In The Last Decade

N. V. Rao

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. V. Rao United States 16 263 256 244 162 159 25 1.0k
James D. Calore United States 16 381 1.4× 232 0.9× 162 0.7× 165 1.0× 164 1.0× 28 936
Allan S. Pollock United States 25 231 0.9× 805 3.1× 371 1.5× 217 1.3× 156 1.0× 39 2.0k
Nobuo Shibata Japan 19 194 0.7× 494 1.9× 73 0.3× 120 0.7× 136 0.9× 63 1.3k
Yi‐Ping Fu United States 23 281 1.1× 753 2.9× 193 0.8× 80 0.5× 209 1.3× 60 1.5k
J Kao United States 12 113 0.4× 760 3.0× 177 0.7× 323 2.0× 177 1.1× 12 1.6k
Govind Gawdi United States 23 99 0.4× 828 3.2× 318 1.3× 242 1.5× 119 0.7× 37 1.6k
Ender Terzıoğlu Türkiye 20 127 0.5× 359 1.4× 58 0.2× 198 1.2× 210 1.3× 54 1.2k
Mark K. Larson United States 21 183 0.7× 347 1.4× 82 0.3× 148 0.9× 86 0.5× 30 1.4k
J S Rhim United States 9 254 1.0× 452 1.8× 227 0.9× 213 1.3× 101 0.6× 12 1.0k
Marlene Absher United States 21 492 1.9× 499 1.9× 129 0.5× 177 1.1× 111 0.7× 52 1.4k

Countries citing papers authored by N. V. Rao

Since Specialization
Citations

This map shows the geographic impact of N. V. Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. V. Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. V. Rao more than expected).

Fields of papers citing papers by N. V. Rao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. V. Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. V. Rao. The network helps show where N. V. Rao may publish in the future.

Co-authorship network of co-authors of N. V. Rao

This figure shows the co-authorship network connecting the top 25 collaborators of N. V. Rao. A scholar is included among the top collaborators of N. V. Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. V. Rao. N. V. Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shukla, R. & N. V. Rao. (2021). CRISPR technology a silver lining in combating COVID-19 pandemic. 18–21.
3.
Rao, N. V. & R. Shukla. (2013). Distribution of Gastrin Immune Reactive Cells in the Alimentary Canal of a Stomachless Hill Stream Loach, Lepidocephalus guntea (Hamilton): An Immuno-Histochemical study. Proceedings of the National Academy of Sciences India Section B Biological Sciences. 83(4). 603–607. 3 indexed citations
4.
Hasegawa, Takafumi, Lise K. Sorensen, Makoto Dohi, et al.. (1997). Induction of Urokinase-Type Plasminogen Activator Receptor by IL-1 β. American Journal of Respiratory Cell and Molecular Biology. 16(6). 683–692. 27 indexed citations
5.
Chang, Jung‐Su, et al.. (1996). Nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 270(6). L931–L940. 65 indexed citations
6.
Hoidal, John R., N. V. Rao, & Beulah H. Gray. (1994). [3] Myeloblastin: Leukocyte proteinase 3. Methods in enzymology on CD-ROM/Methods in enzymology. 244. 61–67. 19 indexed citations
7.
Brubaker, Michael J., William C. Groutas, John R. Hoidal, & N. V. Rao. (1992). Human neutrophil proteinase 3: Mapping of the substrate binding site using peptidyl thiobenzyl esters. Biochemical and Biophysical Research Communications. 188(3). 1318–1324. 33 indexed citations
8.
Haider, S. A. & N. V. Rao. (1992). Oocyte maturation inClarias batrachus. III. Purification and characterization of maturation-inducing steroid. Fish Physiology and Biochemistry. 9(5-6). 505–512. 27 indexed citations
9.
Marshall, Bruce C., Qiang Xu, N. V. Rao, Brent R. Brown, & John R. Hoidal. (1992). Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha.. Journal of Biological Chemistry. 267(16). 11462–11469. 58 indexed citations
10.
Rao, N. V., Nancy Wehner, Bruce C. Marshall, et al.. (1991). Proteinase‐3 (PR‐3): A Polymorphonuclear Leukocyte Serine Proteinase. Annals of the New York Academy of Sciences. 624(1). 60–68. 15 indexed citations
11.
Rao, N. V., et al.. (1990). Sulfated Polysaccharides Prevent Human Leukocyte Elastase-induced Acute Lung Injury and Emphysema in Hamsters. American Review of Respiratory Disease. 142(2). 407–412. 50 indexed citations
12.
Groutas, William C., John R. Hoidal, Michael J. Brubaker, et al.. (1990). Inhibitors of human leukocyte proteinase-3. Journal of Medicinal Chemistry. 33(4). 1085–1087. 19 indexed citations
13.
Bysani, G. Kris, et al.. (1990). Role of cytochrome P-450 in reperfusion injury of the rabbit lung.. Journal of Clinical Investigation. 86(5). 1434–1441. 67 indexed citations
14.
Baser, Michael E., et al.. (1990). Hydroxyl radical generating activity of hydrous but not calcined kaolin is prevented by surface modification with dipalmitoyl lecithin. Journal of Toxicology and Environmental Health. 29(1). 99–108. 6 indexed citations
15.
Kennedy, Thomas P., et al.. (1990). Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron.. Journal of Clinical Investigation. 86(5). 1565–1573. 59 indexed citations
16.
Marshall, Bruce C., et al.. (1990). Alveolar epithelial cell plasminogen activator. Characterization and regulation.. Journal of Biological Chemistry. 265(14). 8198–8204. 51 indexed citations
17.
Kennedy, Thomas P., N. V. Rao, Chris Hopkins, et al.. (1989). Role of reactive oxygen species in reperfusion injury of the rabbit lung.. Journal of Clinical Investigation. 83(4). 1326–1335. 159 indexed citations
18.
Kennedy, Thomas P., Ronald F. Dodson, N. V. Rao, et al.. (1989). Dusts causing pneumoconiosis generate OH and produce hemolysis by acting as fenton catalysts. Archives of Biochemistry and Biophysics. 269(1). 359–364. 82 indexed citations
19.
Baser, M E, et al.. (1989). Differences in lung function and prevalence of pneumoconiosis between two kaolin plants.. Occupational and Environmental Medicine. 46(11). 773–776. 2 indexed citations
20.
Hoidal, John R., D. E. Niewoehner, N. V. Rao, & Margaret S. Hibbs. (1985). The role of neutrophils in the development of cadmium chloride-induced emphysema in lathyrogen-fed hamsters.. PubMed Central. 120(1). 22–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026